Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease.

Goel, Gautam; Tye-Din, Jason A; Qiao, Shuo-Wang; Russell, Amy K; Mayassi, Toufic; Ciszewski, Cezary; Sarna, Vikas K; Wang, Suyue et al. · Sci Adv · 2019

rct · Level II

Where this comes from

Abstract

Celiac disease (CeD), caused by immune reactions to cereal gluten, is treated with gluten -elimination diets. Within hours of gluten exposure, either perorally or extraorally by intradermal injection, treated patients experience gastrointestinal symptoms. To test whether gluten exposure leads to systemic cytokine production time -related to symptoms, series of multiplex cytokine measurements were obtained in CeD patients after gluten challenge. Peptide injection elevated at least 15 plasma cytokines, with IL-2, IL-8, and IL-10 being most prominent (fold-change increase at 4 hours of 272, 11, and 1.2, respectively). IL-2 and IL-8 were the only cytokines elevated at 2 hours, preceding onset of symptoms. After gluten ingestion, IL-2 was the earliest and most prominent cytokine (15-fold change at 4 hours). Supported by studies of patient-derived gluten-specific T cell clones and primary lymphocytes, our observations indicate that gluten-specific CD4<sup>+</sup> T cells are rapidly reactivated by antigen -exposure likely causing CeD-associated gastrointestinal symptoms.

Medical subject headings